Ticker > Company >

Medico Remedies share price

Medico Remedies Ltd.

NSE: MEDICO BSE: 540937 SECTOR: Pharmaceuticals & Drugs  29k   66   4

43.32
-2.27 (-4.98%)
BSE: Today, 11:33 AM

Price Summary

Today's High

₹ 44.85

Today's Low

₹ 43.32

52 Week High

₹ 92.87

52 Week Low

₹ 35

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

359.49 Cr.

Enterprise Value

366.06 Cr.

No. of Shares

8.3 Cr.

P/E

46.82

P/B

6.48

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  6.69

CASH

0.18 Cr.

DEBT

6.75 Cr.

Promoter Holding

73.34 %

EPS (TTM)

₹  0.93

Sales Growth

3.19%

ROE

17.23 %

ROCE

21.9%

Profit Growth

14.49 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year3.19%
3 Year5.79%
5 Year8.21%

Profit Growth

1 Year14.49%
3 Year47.38%
5 Year39.49%

ROE%

1 Year17.23%
3 Year16.39%
5 Year12.62%

ROCE %

1 Year21.9%
3 Year19.62%
5 Year15.33%

Debt/Equity

0.1289

Price to Cash Flow

147.46

Interest Cover Ratio

14.7643

CFO/PAT (5 Yr. Avg.)

0.249319965487614

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 73.34 0.00
Jun 2024 73.34 0.00
Mar 2024 73.34 0.00
Dec 2023 73.34 0.00
Sep 2023 73.34 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 47.3784453470011% for the Past 3 years.
  • Company has a healthy Interest coverage ratio of 14.7643.
  • The company has an efficient Cash Conversion Cycle of 34.1496 days.
  • The company has a high promoter holding of 73.34%.

 Limitations

  • The company has shown a poor revenue growth of 5.79405204970926% for the Past 3 years.
  • The company is trading at a high PE of 46.82.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 42.36 29.77 41.32 30.8 39.35
Total Expenditure 39.28 27.04 36.68 27.99 36.94
Operating Profit 3.08 2.73 4.65 2.81 2.41
Other Income 0.96 0.27 0.58 0.29 0.68
Interest 0.18 0.22 0.25 0.18 0.21
Depreciation 0.71 0.72 0.74 0.75 0.75
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.14 2.06 4.25 2.18 2.13
Tax 0.72 0.62 1.15 0.6 0.58
Profit After Tax 2.43 1.45 3.1 1.58 1.56
Adjusted EPS (Rs) 0.29 0.17 0.37 0.19 0.19

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 88.64 122.39 121.02 140.44 144.92
Total Expenditure 85.8 117.15 113.69 130.96 132.01
Operating Profit 2.84 5.24 7.33 9.48 12.91
Other Income 2.1 1.03 2.03 4.09 2.13
Interest 1.06 0.92 0.66 0.75 0.82
Depreciation 1.66 1.65 2.22 2.72 2.88
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.22 3.7 6.48 10.1 11.33
Tax 0.58 1.11 1.67 2.86 3.04
Net Profit 1.63 2.59 4.81 7.24 8.29
Adjusted EPS (Rs.) 0.2 0.31 0.58 0.87 1

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.15 4.15 16.6 16.6 16.6
Total Reserves 25.72 28.31 19.98 27.25 35.77
Borrowings 4.71 4.95 0.9 0.25 0.25
Other N/C liabilities 0.22 0.26 1.6 1.84 1.01
Current liabilities 40.48 37.95 39.57 43.15 44.58
Total Liabilities 75.27 75.62 78.65 89.08 98.21
Assets
Net Block 12.55 15.31 18.03 21.83 21.49
Capital WIP 2.28 0 0 0 0
Intangible WIP 0 0 0 0.07 0
Investments 0.15 0.11 0 0 0.2
Loans & Advances 3.59 1.72 1.54 0.85 0.56
Other N/C Assets 0.06 0 0.07 0.16 0.18
Current Assets 56.64 58.48 59.01 66.17 75.78
Total Assets 75.27 75.62 78.65 89.08 98.21
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 2.22 3.68 6.48 10.1 11.33
Adjustment 2.14 2.57 2.52 2.71 3.53
Changes in Assets & Liabilities -2.81 -16.63 -1.34 -2.15 -9.26
Tax Paid -0.54 -0.93 -1.79 -2.5 -3.17
Operating Cash Flow 0.97 -11.31 5.86 8.17 2.44
Investing Cash Flow -3.08 -16.96 -1.76 -6.6 -2.68
Financing Cash Flow 2.6 18.28 -5.77 -1.82 -0.49
Net Cash Flow 0.48 -9.99 -1.67 -0.25 -0.73

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 73.34 73.34 73.34 73.34 73.34
haresh kapurlal mehta 16.56 28.45 20.76 20.76 20.76
harshit h mehta huf 0.87 0.87 0.87 0.87 0.87
harshit haresh mehta 9.11 9.11 11.47 11.47 11.47
priyal rishit mehta 6.27 6.27 6.27 6.27 6.27
rishit hareshbhai mehta 9.49 9.49 14.82 14.82 14.82
rita h mehta 10.40 10.40 10.40 10.40 10.40
shweta harshit mehta 8.75 8.75 8.75 8.75 8.75
haresh k mehta huf 11.90 - - - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 26.66 26.66 26.66 26.66 26.66
llp - - - 0.86 0.99
ravi goyal huf 1.77 1.92 - - 3.95
sanjay narendra bansal 1.50 1.50 1.50 1.50 1.50
vijaygopal parasram atal 2.08 2.08 2.08 2.08 2.08
ravi goyal (huf) . - - 3.95 3.95 -
escorp asset management l... 1.78 1.78 1.78 - -
kanchan rani 1.33 1.33 - - -
moneyplant gold & jewelle... - 1.20 - - -
nopea capital services pr... 1.90 1.90 - - -
emrald commercial limited... 2.07 - - - -
s k growth fund pvt ltd 1.09 - - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Company News

Medico Remedies informs about disclosure 20 Nov, 1:10 PM Medico Remedies - Quaterly Results 12 Nov, 11:52 AM Medico Remedies - Quaterly Results 12 Nov, 11:52 AM Medico Remedies - Quaterly Results 12 Aug, 5:18 PM Medico Remedies - Quaterly Results 12 Aug, 5:18 PM Medico Remedies - Quaterly Results 9 May, 5:15 PM Medico Remedies - Quaterly Results 9 May, 5:15 PM Medico Remedies - Quaterly Results 9 May, 5:15 PM Medico Remedies - Quaterly Results 12 Feb, 4:29 PM Medico Remedies - Quaterly Results 12 Feb, 4:29 PM Medico Remedies - Quaterly Results 12 Feb, 4:29 PM Medico Remedies informs about investor presentation 11 Jan, 2:46 PM Medico Remedies informs about disclosure 3 Nov, 12:42 PM Medico Remedies submits intimation of cancellation of inter-se transfer of shares 23 Oct, 2:53 PM Medico Remedies informs about newspaper publication 11 Aug, 1:50 PM Medico Remedies - Quaterly Results 10 Aug, 3:49 PM Medico Remedies - Quaterly Results 10 Aug, 3:49 PM Medico Remedies informs about newspaper publication 24 Jul, 12:41 PM Medico Remedies informs about press release 21 Jul, 12:13 PM Medico Remedies to foray into ointment manufacturing segment 15 May, 9:29 AM Medico Remedies - Quaterly Results 11 May, 7:56 PM Medico Remedies - Quaterly Results 11 May, 7:56 PM Medico Remedies submits board meeting intimation 3 May, 4:49 PM Medico Remedies - Quaterly Results 10 Feb, 5:23 PM Medico Remedies - Quaterly Results 10 Feb, 5:23 PM Medico Remedies informs about board meeting 14 Jan, 11:22 AM Medico Remedies informs about trading window closure 27 Dec, 3:02 PM Medico Remedies - Quaterly Results 12 Nov, 9:24 PM Medico Remedies informs about newspaper advertisement 30 Aug, 4:52 PM Medico Remedies informs about RPT disclosures 16 Aug, 4:28 PM Medico Remedies informs about board meeting 12 May, 5:08 PM Medico Remedies submits 27th AGM notice 8 Sep, 4:19 PM Medico Remedies informs about revised disclosure 2 Jun, 2:03 PM Medico Remedies informs about disclosure 21 Apr, 12:51 PM Medico Remedies informs about disclosure 21 Apr, 12:19 PM

Medico Remedies Stock Price Analysis and Quick Research Report. Is Medico Remedies an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Medico Remedies and its performance over the period of time. Medico Remedies stock price today is Rs 43.33.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Medico Remedies cash from the operating activity was Rs 2.4379 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Medico Remedies has a Debt to Equity ratio of 0.1289 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Medico Remedies , the EPS growth was 14.4969 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Medico Remedies has OPM of 8.90783718267993 % which is a bad sign for profitability.
     
  • ROE: Medico Remedies have a average ROE of 17.2343 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Medico Remedies is Rs 43.33. One can use valuation calculators of ticker to know if Medico Remedies share price is undervalued or overvalued.
Last Updated on:
Brief about Medico Remedies
X